Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Will Walmart's (WMT) Foray in Health Insurance be a Bane?

Published 07/10/2020, 01:31 AM
Updated 07/09/2023, 06:31 AM

Retail behemoth Walmart (NYSE:WMT) Inc. WMT is planning to sell health insurance policies to expand into the healthcare space via its newly-formed subsidiary Walmart Insurance Services LLC.

Although at present, the company offers access to insurance information in its Walmart Health locations, it is in the process of recruiting agents to sell Medicare Advantage (MA) Insurance policies.

The new job postings pertaining to the enrollment of health insurance agents for its health insurance business are meant for Texas, a state where the managed care organization market share is dominated by UnitedHealthcare Inc. UNH the largest MA carrier and Humana Inc (NYSE:HUM) HUM, the second in line. Other players in the MA market are Anthem Inc. ANTM, CVS Health Corp (NYSE:CVS). CVS and Centene (NYSE:CNC) Corp. CNC.

The retail giant already has a presence in healthcare space via its 18 Care Clinics that are present across Texas, Georgia and South Carolina, providing treatment for chronic and acute illnesses. The retailer has been making efforts to dive deeper into the healthcare space. In this regard, last month, Walmart acquired the technology platform CareZone for $200 million. It is a venture-backed startup that develops apps to help people manage medications and chronic diseases. The company also partnered with Humana and Quest Diagnostics (NYSE:DGX) to offer its members a drive-through coronavirus testing facility at Walmart Neighborhood Market drive-through pharmacy locations across the country.

Retailers Eye a Slice of Healthcare Space

Walmart is not the first retailer showing a keen interest in the healthcare sphere. Recently, Amazon (NASDAQ:AMZN) entered into a joint venture with JP Morgan and Berkshire Hathaway to manage insurance for their employees. The company also expressed eagerness in pharmacy business.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Retailers upped their game for the nearly $3-trillion worth healthcare sector, which accounts for approximately 18% of U.S. GDP.

Per Centers for Medicare and Medicaid Services, the total healthcare spending in the United States climbed to $3.4 trillion in 2016 and is expected to reach $5.5 trillion by 2020. The sheer size of this ever-growing market, which is much in need of innovation, attracted retailers that are always sniffing out business opportunities. And retailers are right in doing so as there is little doubt that spending on medical care will continue to rise.

Medicare Advantage, a private version of the Governemnt-sponsored Medicare policies is set to grow, given its exciting benefits and the growing baby boomer cohort, the main customers of these plans.

Also, the continued decrease in member premiums, new incentives and less attractive medigap options are all contributing to Medicare Advantage growth. With 10,000 boomers aging into the program every day, and beneficiaries being offered a larger selection of plans each new season, Medicare Advantage admission growth projections will only move north and continue to take on a larger role in the Medicare program over the next decade.

Medicare Advantage enrollment forecast by The Congressional Budget Office (CBO) sees continued growth over the next decade with Medicare Advantage enrollment expected to cover about 47% of beneficiaries by 2029.

Walmart is therefore eyeing the lucrative medicare business. Its shoppers' mix has an average age of more than 50 years. A better way to generate revenues from this customer base would be to sell them their desired healthcare product/services.

Disruption in the Cards?

Considering the health insurance industry, which was concentrated in a handful of bigwigs who commanded product pricing and service offerings and had an upper hand in dealing with customers, will find themselves in a radically changed scenario. Players in this space already had to make fundamental changes in their business operations and attitude since the enactment of Obamacare in 2010 that put a check on malpractices to protect customers’ interest. Now, the entry of participants who are already well-established in their own fields and enjoy customer loyalty, will give the traditional healthcare players a jolt.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The need of the hour for healthcare entities is a razor-sharp focus on innovation and service to protect their market share that they have held for ages. This will help them save their space from retail invasion.

Among the stocks mentioned above, Humana, Centene and Anthem currently carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

These Stocks Are Poised to Soar Past the Pandemic

The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.

Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.

See the 5 high-tech stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

UnitedHealth Group Incorporated (NYSE:UNH): Free Stock Analysis Report

Walmart Inc. (WMT): Free Stock Analysis Report

Humana Inc. (HUM): Free Stock Analysis Report

CVS Health Corporation (CVS): Free Stock Analysis Report

Centene Corporation (CNC): Free Stock Analysis Report

Anthem, Inc. (ANTM): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.